Updated Jul 16, 2026
Sethuraman Natarajan has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.15M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-04 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale | 25.9K | $15.39 | $399K |
| 2026-03-03 | TRDA | Entrada Therapeutics, Inc. | F — Tax withholding / forfeiture | 7.6K | $11.76 | $89K |
| 2026-03-03 | TRDA | Entrada Therapeutics, Inc. | F — Tax withholding / forfeiture | 3.9K | $11.66 | $45K |
| 2026-03-03 | TRDA | Entrada Therapeutics, Inc. | A — Grant or award | 55.8K | $0.00 | |
| 2025-09-02 | TRDA | Entrada Therapeutics, Inc. | F — Tax withholding / forfeiture | 1.8K | $5.43 | $10K |
| 2024-12-03 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale [10b5-1] | 11.7K | $20.15 | $236K |
| 2024-12-03 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale [10b5-1] | 4.1K | $20.26 | $83K |
| 2024-12-03 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale [10b5-1] | 100 | $20.00 | $2K |
| 2024-11-13 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale [10b5-1] | 2.7K | $20.04 | $54K |
| 2024-11-13 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale [10b5-1] | 1.4K | $20.01 | $28K |
| 2024-11-06 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale [10b5-1] | 2.7K | $19.32 | $53K |
| 2024-11-06 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale [10b5-1] | 9.6K | $18.71 | $179K |
| 2024-11-06 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale [10b5-1] | 5.2K | $18.18 | $94K |
| 2024-11-06 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale [10b5-1] | 749 | $18.02 | $13K |
| 2024-10-18 | TRDA | Entrada Therapeutics, Inc. | S — Open-market sale [10b5-1] | 600 | $18.00 | $11K |
Sethuraman Natarajan is a corporate insider — currently tracked as President, Research & Develop. of Entrada Therapeutics, Inc. (TRDA). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 11 open-market sales ($1.15M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sethuraman Natarajan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.